You are here
Aduro Announces Changes to its Board of Directors
BERKELEY, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced the appointment of David H. Mack, Ph.D., President and CEO of PMV Pharmaceuticals, to its Board of Directors effective February 19, 2019. In addition, Frank McCormick, Ph.D., F.R.S., a director since Aduro’s inception, will transition off the company’s Board and to the company’s Scientific Advisory Board.
Thursday, February 21, 2019 - 08:00